Displaying 1 - 12 of 13
Metabolism, Alcohol & Toxicity

Novo Nordisk and Echosens: "Clinical challenge: Updates on the non-invasive toolbox for NASH and Fibrosis" (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

The Growing Burden of MASLD/MASH: A Call to Action

Webcasts
View
Metabolism, Alcohol & Toxicity

AKH: Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging D...

Webcasts
View
Metabolism, Alcohol & Toxicity

THR-β Agonists and Other Disease-specific Therapies Poised to Change the Paradigm

Webcasts
View
Metabolism, Alcohol & Toxicity

Rising to the Need to Improve Diagnosis in the Era of Disease-specific Therapy

Webcasts
View
Metabolism, Alcohol & Toxicity

Clinical Case Challenge: Integrating MASLD/MASH-Specific Therapy into Practice

Webcasts
View
Metabolism, Alcohol & Toxicity

Q&A

Webcasts
View
Metabolism, Alcohol & Toxicity
Introduction

Introduction

Webcasts
View
Metabolism, Alcohol & Toxicity
Agile 3+ and Agile 4: two new scores to better identify advanced fibrosis and cirrhosis in NAFLD patients

Agile 3+ and Agile 4: two new scores to better identify advanced fibrosis and cirrhosis in NAFLD patients

Webcasts
View
Metabolism, Alcohol & Toxicity
Clinical cases presentation and discussion

Clinical cases presentation and discussion

Webcasts
View
Metabolism, Alcohol & Toxicity
FAST score for identification of active fibrotic NASH

FAST score for identification of active fibrotic NASH

Webcasts
View
Metabolism, Alcohol & Toxicity
Q&A

Q&A

Webcasts
View
Displaying 1 - 12 of 13